Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CTSO
CTSO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CTSO News
Cytosorbents Q4 2025 Earnings Call Insights
6d ago
seekingalpha
CytoSorbents Reports 4% Revenue Growth in 2025
5d ago
Yahoo Finance
Cytosorbents Reports Q4 and Full Year 2025 Financial Results
6d ago
seekingalpha
Cytosorbents to Announce Q4 Earnings on March 25
Mar 24 2026
seekingalpha
CytoSorbents Launches HotSwap™ to Optimize Critical Care Treatment
Mar 19 2026
Newsfilter
CytoSorbents Launches HotSwap™ to Optimize Critical Care Therapy
Mar 19 2026
PRnewswire
CytoSorbents Announces Q4 and Full Year 2025 Earnings Release Date
Mar 05 2026
PRnewswire
CytoSorbents (CTSO) Projects $37M Revenue for 2025, FDA Meeting Scheduled
Jan 12 2026
PRnewswire
CytoSorbents Reports $37M in Q3 Sales; CEO to Join Virtual Discussion
Dec 10 2025
PRnewswire
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London
Nov 17 2025
PRnewswire
HC Wainwright & Co. Upholds Neutral Rating for Cytosorbents (CTSO)
Nov 15 2025
NASDAQ.COM
CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update
Nov 13 2025
PRnewswire
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London
Nov 11 2025
PRnewswire
In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer
Oct 28 2025
PRnewswire
CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen
Sep 29 2025
PRnewswire
CytoSorbents Provides Regulatory Update on DrugSorb-ATR and Intends to Submit New De Novo Application
Sep 16 2025
NASDAQ.COM
Show More News
